FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (IB) or their pharmaceutically acceptable salts, a pharmaceutical composition and use thereof in preparing medicinal agents.
EFFECT: novel compounds having a selective inhibitory effect on KRAS gene mutation, which can be used in preparing anticancer drugs, are obtained.
22 cl, 350 ex, 9 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
| SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
| DERIVATIVES OF 1,2,4-TRIAZINE-4-AMINE | 2011 |
|
RU2625791C2 |
| DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
| CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
| ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
| NOVEL LIGANDS OF ESTROGEN RECEPTORS | 2009 |
|
RU2492164C2 |
| NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
